The way acute repetitive seizures are managed is undergoing a significant transformation, thanks to the development of intranasal rescue therapies. These innovative formulations offer a convenient, non-invasive alternative to traditional injectable treatments, enabling faster intervention and improving patient outcomes. This shift is a major driver of growth in the Acute Repetitive Seizures Market.

The Acute Repetitive Seizures Market is experiencing robust growth, with intranasal therapies representing a significant and fast-growing segment. UCB's Nayzilam (midazolam nasal spray) and Neurelis' VALTOCO (diazepam nasal spray) are leading examples of this trend. These products are designed for easy administration by caregivers, reducing the need for emergency medical intervention. In Q1 2024, UCB received FDA approval for an expanded indication for Nayzilam, allowing its use in pediatric patients aged 6 to 11 years. In Q3 2024, Neurelis received Health Canada approval for VALTOCO.

The market is also benefiting from ongoing research into novel intranasal therapies. In Q3 2025, Neurelis received FDA Fast Track designation for its investigational intranasal rescue therapy for acute repetitive seizures. This designation is expected to expedite the development and review process, bringing new treatment options to patients faster. As healthcare systems continue to prioritize patient-centric care and convenience, intranasal rescue therapies are expected to capture a growing share of the Acute Repetitive Seizures Market.

People Also Ask

• What is the best rescue medication for seizure clusters?
  Intranasal benzodiazepines, such as midazolam nasal spray (Nayzilam) and diazepam nasal spray (VALTOCO), are effective rescue medications for seizure clusters.

• Can caregivers administer rescue therapy?
  Yes, intranasal rescue therapies are designed for easy administration by caregivers, enabling faster intervention outside of hospital settings.

Tags: #IntranasalTherapy #AcuteRepetitiveSeizures #RescueMedication #Epilepsy #Nayzilam #VALTOCO